Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony M Marchese

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Opinion in Virology|May 16, 2021
Innate immunity and HBV persistenceCarolina Chiale, Anthony M Marchese, Michael D Robek
Vaccine|October 9, 2022
With established safe and effective use, protein vaccines offer another choice against COVID-19Anthony M Marchese, Hadi Beyhaghi, Walter A Orenstein
NPJ Vaccines|November 23, 2021
Virus-based vaccine vectors with distinct replication mechanisms differentially infect and activate dendritic cellsCarolina Chiale, Anthony M Marchese, Yoichi Furuya, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 22, 2019
Mechanisms of Innate Immune Activation by a Hybrid Alphavirus-Rhabdovirus Vaccine PlatformAnthony M Marchese, Carolina Chiale, Safiehkhatoon Moshkani, et al.
Expert Review of Vaccines|June 30, 2023
Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccinesAnthony M Marchese, Raj Kalkeri, Muruga Vadivale, et al.
The Journal of Infectious Diseases|November 22, 2023
The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted ReviewAnthony M Marchese, Matthew Rousculp, John Macbeth, et al.
Vaccine|February 1, 2025
Efficacy, immunogenicity, and safety of the Novavax COVID-19 vaccine in immunocompromised patients: A targeted literature reviewManuela H Gschwend, Anthony M Marchese, Dirk Poelaert, et al.
Vaccine|December 6, 2024
Local and systemic reactogenicity after mRNA and protein-based COVID-19 vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomized phase 2 trial (COV-BOOST)Anthony M Marchese, Hadi Beyhaghi, Matthew D Rousculp, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|March 17, 2022
Recommendations for Neuromodulation in Diabetic Neuropathic PainZachary T Olmsted, Amir Hadanny, Anthony M Marchese, et al.
Journal of Virology|February 14, 2020
Mucin-Like Domain of Ebola Virus Glycoprotein Enhances Selective Oncolytic Actions against Brain TumorsXue Zhang, Tingting Zhang, John N Davis, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Opinion in Virology|May 16, 2021
Innate immunity and HBV persistenceCarolina Chiale, Anthony M Marchese, Michael D Robek
Vaccine|October 9, 2022
With established safe and effective use, protein vaccines offer another choice against COVID-19Anthony M Marchese, Hadi Beyhaghi, Walter A Orenstein
NPJ Vaccines|November 23, 2021
Virus-based vaccine vectors with distinct replication mechanisms differentially infect and activate dendritic cellsCarolina Chiale, Anthony M Marchese, Yoichi Furuya, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 22, 2019
Mechanisms of Innate Immune Activation by a Hybrid Alphavirus-Rhabdovirus Vaccine PlatformAnthony M Marchese, Carolina Chiale, Safiehkhatoon Moshkani, et al.
Expert Review of Vaccines|June 30, 2023
Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccinesAnthony M Marchese, Raj Kalkeri, Muruga Vadivale, et al.
The Journal of Infectious Diseases|November 22, 2023
The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted ReviewAnthony M Marchese, Matthew Rousculp, John Macbeth, et al.
Vaccine|February 1, 2025
Efficacy, immunogenicity, and safety of the Novavax COVID-19 vaccine in immunocompromised patients: A targeted literature reviewManuela H Gschwend, Anthony M Marchese, Dirk Poelaert, et al.
Vaccine|December 6, 2024
Local and systemic reactogenicity after mRNA and protein-based COVID-19 vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomized phase 2 trial (COV-BOOST)Anthony M Marchese, Hadi Beyhaghi, Matthew D Rousculp, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|March 17, 2022
Recommendations for Neuromodulation in Diabetic Neuropathic PainZachary T Olmsted, Amir Hadanny, Anthony M Marchese, et al.
Journal of Virology|February 14, 2020
Mucin-Like Domain of Ebola Virus Glycoprotein Enhances Selective Oncolytic Actions against Brain TumorsXue Zhang, Tingting Zhang, John N Davis, et al.
Pageof 3